Beacon claimed the findings represent the first time a treatment for X-linked retinitis pigmentosa, a rare and potentially ...
The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found.
Scientists have discovered a powerful gene-targeting system in viruses. Billions of years old, VIPR seems to predate CRISPR ...
Researchers led by Assistant Professor Lynn Yap of the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, have uncovered new insights into how unspecialized cells, also ...
Exclusive: Research and invention agency hopes to harness ‘powers of biotechnology’ for purpose of conservation ...
Understanding gene regulation may be key to interpreting human disease genetics. Genes are regulated in part by stretches of ...
FDA approves Fayuvi (rebisufligene etisparvovec-hopf), the first gene therapy for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA).
FAYUVI™ is the first FDA-approved gene therapy manufactured using the Andelyn AAV Curator® Platform process. Its commercial ...
Fayuvi, previously known as UX111, uses an adeno-associated viral vector to deliver a working copy of the SGSH gene into the patient’s cells. It marks the first FDA-approved therapy designed to ...
Beacon’s laru-zova gene therapy improved low-light vision in a pivotal XLRP trial, paving the way for discussions with regulators.
GlobalData on MSN
FDA approves first gene therapy for Sanfilippo syndrome type A
With a $3.95m price tag, Fayuvi – a one-time gene therapy – is one of the most expensive drugs on the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results